NASDAQ:ESTA - Establishment Labs Stock Price, Forecast & News

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Establishment Labs Holdings Inc (NASDAQ:ESTA) released its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.51) by $0.11. The business earned $22.85 million during the quarter, compared to analyst estimates of $20 million. Establishment Labs had a negative return on equity of 75.10% and a negative net margin of 52.76%. View Establishment Labs' Earnings History.

Establishment Labs is scheduled to release their next quarterly earnings announcement on Wednesday, March 18th 2020. View Earnings Estimates for Establishment Labs.

Establishment Labs updated its fourth quarter 2019 After-Hours earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $23.5-24.5 million, compared to the consensus revenue estimate of $21.79 million.

3 brokers have issued 1 year target prices for Establishment Labs' shares. Their forecasts range from $29.00 to $40.00. On average, they anticipate Establishment Labs' stock price to reach $35.33 in the next twelve months. This suggests a possible upside of 47.8% from the stock's current price. View Analyst Price Targets for Establishment Labs.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Establishment Labs.

News articles about ESTA stock have been trending very positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Establishment Labs earned a media sentiment score of 3.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Establishment Labs.

Establishment Labs saw a increase in short interest in January. As of January 31st, there was short interest totalling 760,300 shares, an increase of 10.1% from the January 15th total of 690,500 shares. Based on an average daily volume of 92,200 shares, the short-interest ratio is currently 8.2 days. Approximately 4.8% of the company's stock are sold short. View Establishment Labs' Current Options Chain.

Some companies that are related to Establishment Labs include Avanos Medical (AVNS), Inogen (INGN), RTI Surgical (RTIX), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Bionik Laboratories (BNKL), NanoVibronix (NAOV), Rewalk Robotics (RWLK), Allied Healthcare Products (AHPI), Ocugen (OCGN) and Precision Therapeutics (POAI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include Sientra (SIEN), AbbVie (ABBV), Enterprise Products Partners (EPD), Evolus (EOLS), Huntington Bancshares (HBAN), Methanex (MEOH), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and Conduent (CNDT).

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Establishment Labs' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include JW Asset Management LLC (15.13%), Perceptive Advisors LLC (5.10%), UBS Group AG (1.97%), BigSur Wealth Management LLC (0.73%), Magnetar Financial LLC (0.72%) and Cowen AND Company LLC (0.58%). Company insiders that own Establishment Labs stock include David L Bonvenuto, Jw Asset Management, Llc and Nicholas Sheridan Lewin. View Institutional Ownership Trends for Establishment Labs.

ESTA stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC. View Insider Buying and Selling for Establishment Labs.

ESTA stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, BigSur Wealth Management LLC, Cowen AND Company LLC, Calamos Advisors LLC, Russell Investments Group Ltd., Kornitzer Capital Management Inc. KS, Magnetar Financial LLC and Granite Point Capital Management L.P.. Company insiders that have bought Establishment Labs stock in the last two years include David L Bonvenuto, Jw Asset Management, Llc and Nicholas Sheridan Lewin. View Insider Buying and Selling for Establishment Labs.

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ESTA stock can currently be purchased for approximately $23.91.

Establishment Labs has a market capitalization of $492.55 million and generates $61.21 million in revenue each year. The company earns $-21,100,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Establishment Labs employs 505 workers across the globe.View Additional Information About Establishment Labs.

The official website for Establishment Labs is http://www.establishmentlabs.com/.

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]